Evotec and Asahi Kasei up drug discovery collaboration
German CRO Evotec says it will invest in its staff and infrastructure to help service a drug discovery deal with Japan’s Asahi Kasei Pharma.
Archives for January 23, 2017
GCP 'Renovation' paper outlines revisions to ICH E8 and E6
ICH is currently seeking public comment on proposed "modernizations" to the clinical trial design, planning, management, and conduct guidelines ICH E8 and E6.
Amatsigroup buys French Pyrofree manufacturing specialist Disposable-Lab
Amatsigroup has acquired single-use processing equipment and packaging tech firm Disposable-Lab SAS as part of a plan to increase its revenue to €50m this year.
WuXi AppTec acquires preclinical CRO
WuXi AppTec has acquired Shanghai-based HD Biosciences (HDB), a biology-focused preclinical contract research organization (CRO).
EDQM outlines ICH Q3D impurities testing guideline integration plan
The EDQM has set out how it will integrate risk-based elemental impurities testing into the European Pharmacopoeia.
Ocular Therapeutix has resubmitted Dextenza to US FDA after CRL
Ocular Therapeutix Inc. has resubmitted its eye pain drug Dextenza to the US FDA claiming it has solved manufacturing problems that saw the agency reject the drug in July.